Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer

Clinical trial NCT00719173 · COMPLETED

Trial details

NCT number: NCT00719173
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Nausea and Vomiting

Start date: 2005-08-01
Primary completion: 2010-10-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.